Medivir AB: New Executive Vice President Commercial Appointed

Published: May 15, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Medivir AB (STO:MVIRB), a research-based specialty pharmaceutical company focused on infectious diseases, announced today that it has appointed Henric Juserius to be the new head of the company's commercial activities. Henric, who will have overall responsibility for Medivir’s pharmaceutical marketing and sales, will join the company in August 2012 and will be part of the management team.

Back to news